These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 9354617

  • 41. Thrombin specificity.
    Guillin MC, Bezeaud A, Bouton MC, Jandrot-Perrus M.
    Thromb Haemost; 1995 Jul; 74(1):129-33. PubMed ID: 8578445
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Inhibition of trypsin and thrombin by amino(4-amidinophenyl)methanephosphonate diphenyl ester derivatives: X-ray structures and molecular models.
    Bertrand JA, Oleksyszyn J, Kam CM, Boduszek B, Presnell S, Plaskon RR, Suddath FL, Powers JC, Williams LD.
    Biochemistry; 1996 Mar 12; 35(10):3147-55. PubMed ID: 8605148
    [Abstract] [Full Text] [Related]

  • 44. Synthesis of novel thrombin inhibitors. Use of ring-closing metathesis reactions for synthesis of P2 cyclopentene- and cyclohexenedicarboxylic acid derivatives.
    Thorstensson F, Kvarnström I, Musil D, Nilsson I, Samuelsson B.
    J Med Chem; 2003 Mar 27; 46(7):1165-79. PubMed ID: 12646027
    [Abstract] [Full Text] [Related]

  • 45. Structure of the hirulog 3-thrombin complex and nature of the S' subsites of substrates and inhibitors.
    Qiu X, Padmanabhan KP, Carperos VE, Tulinsky A, Kline T, Maraganore JM, Fenton JW.
    Biochemistry; 1992 Dec 01; 31(47):11689-97. PubMed ID: 1445905
    [Abstract] [Full Text] [Related]

  • 46. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
    Qasim MA, Lu SM, Ding J, Bateman KS, James MN, Anderson S, Song J, Markley JL, Ganz PJ, Saunders CW, Laskowski M.
    Biochemistry; 1999 Jun 01; 38(22):7142-50. PubMed ID: 10353824
    [Abstract] [Full Text] [Related]

  • 47. Molecular Interactions of Thrombin.
    Tulinsky A.
    Semin Thromb Hemost; 1996 Jun 01; 22(2):117-24. PubMed ID: 8807707
    [Abstract] [Full Text] [Related]

  • 48. Crystal structure of enteropeptidase light chain complexed with an analog of the trypsinogen activation peptide.
    Lu D, Fütterer K, Korolev S, Zheng X, Tan K, Waksman G, Sadler JE.
    J Mol Biol; 1999 Sep 17; 292(2):361-73. PubMed ID: 10493881
    [Abstract] [Full Text] [Related]

  • 49. Novel azapeptide inhibitors of hepatitis C virus serine protease.
    Bailey MD, Halmos T, Goudreau N, Lescop E, Llinàs-Brunet M.
    J Med Chem; 2004 Jul 15; 47(15):3788-99. PubMed ID: 15239657
    [Abstract] [Full Text] [Related]

  • 50. Structure-based design of residue 1 analogs of the direct thrombin inhibitor pentapeptide FM 19.
    Girnys EA, Sobczyk-Kojiro K, Mosberg HI.
    Chem Biol Drug Des; 2010 Jan 15; 75(1):35-9. PubMed ID: 19954432
    [Abstract] [Full Text] [Related]

  • 51. Structural and kinetic analysis of caspase-3 reveals role for s5 binding site in substrate recognition.
    Fang B, Boross PI, Tozser J, Weber IT.
    J Mol Biol; 2006 Jul 14; 360(3):654-66. PubMed ID: 16781734
    [Abstract] [Full Text] [Related]

  • 52. Conserved mode of peptidomimetic inhibition and substrate recognition of human cytomegalovirus protease.
    Tong L, Qian C, Massariol MJ, Déziel R, Yoakim C, Lagacé L.
    Nat Struct Biol; 1998 Sep 14; 5(9):819-26. PubMed ID: 9731777
    [Abstract] [Full Text] [Related]

  • 53. Synthesis and characterization of more potent analogues of hirudin fragment 1-47 containing non-natural amino acids.
    De Filippis V, Quarzago D, Vindigni A, Di Cera E, Fontana A.
    Biochemistry; 1998 Sep 29; 37(39):13507-15. PubMed ID: 9753436
    [Abstract] [Full Text] [Related]

  • 54. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ, Eichinger A, Stoop AA, Bode W, Pannekoek H, Horrevoets AJ.
    J Mol Biol; 1999 Oct 29; 293(3):613-27. PubMed ID: 10543954
    [Abstract] [Full Text] [Related]

  • 55. The 2.0 A crystal structure and substrate specificity of the KDEL-tailed cysteine endopeptidase functioning in programmed cell death of Ricinus communis endosperm.
    Than ME, Helm M, Simpson DJ, Lottspeich F, Huber R, Gietl C.
    J Mol Biol; 2004 Mar 05; 336(5):1103-16. PubMed ID: 15037072
    [Abstract] [Full Text] [Related]

  • 56. Recruiting Zn2+ to mediate potent, specific inhibition of serine proteases.
    Katz BA, Luong C.
    J Mol Biol; 1999 Sep 24; 292(3):669-84. PubMed ID: 10497030
    [Abstract] [Full Text] [Related]

  • 57. Bound structures of novel P3-P1' beta-strand mimetic inhibitors of thrombin.
    St Charles R, Matthews JH, Zhang E, Tulinsky A.
    J Med Chem; 1999 Apr 22; 42(8):1376-83. PubMed ID: 10212123
    [Abstract] [Full Text] [Related]

  • 58. Structural analysis of thrombin complexed with potent inhibitors incorporating a phenyl group as a peptide mimetic and aminopyridines as guanidine substitutes.
    Bone R, Lu T, Illig CR, Soll RM, Spurlino JC.
    J Med Chem; 1998 Jun 04; 41(12):2068-75. PubMed ID: 9622548
    [Abstract] [Full Text] [Related]

  • 59. Interaction of Kazal-type inhibitor domains with serine proteinases: biochemical and structural studies.
    Schlott B, Wöhnert J, Icke C, Hartmann M, Ramachandran R, Gührs KH, Glusa E, Flemming J, Görlach M, Grosse F, Ohlenschläger O.
    J Mol Biol; 2002 Apr 26; 318(2):533-46. PubMed ID: 12051857
    [Abstract] [Full Text] [Related]

  • 60. The crystal structure of human alpha-thrombin complexed with LY178550, a nonpeptidyl, active site-directed inhibitor.
    Chirgadze NY, Sall DJ, Klimkowski VJ, Clawson DK, Briggs SL, Hermann R, Smith GF, Gifford-Moore DS, Wery JP.
    Protein Sci; 1997 Jul 26; 6(7):1412-7. PubMed ID: 9232642
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.